男人宫殿

EXHIBIT 23.1

Consent of Independent Auditors

We consent to the incorporation by reference in the Registration Statement (Form S-8 No.听333-59490) pertaining to the 2000 Stock Option Plan of eXegenics Inc., formerly Cytoclonal Pharmaceutics, Inc., the Registration Statement (Form S-8 No.听333-11691) pertaining to the 1996 Stock Option Plan of eXegenics Inc., the Registration Statement (Form S-8 No.听333-86201) pertaining to the 1996 Stock Option Plan of eXegenics Inc., the Registration Statement (Form听S-8 No.333-37049) pertaining to the 1992 Stock Option Plan of eXegenics Inc., the Registration Statement (Form S-3 No.听333-66003), the Registration Statement (Form S-3 No.听333-33838) and the Registration Statement (Form听SB-2 No.333-91802) and related prospectuses of our report dated February听27, 2004, with respect to the financial statements of eXegenics Inc. included in the Annual Report (Form 10-K) for the year ended December听31, 2003.

BDO Seidman, LLP
Dallas, Texas
April听2, 2004